Mindfulness in psychiatry - Where are we now? by Groves, P
Over the past 15 years there has been a surge of interest
in mindfulness as a therapeutic modality. Mindfulness is
being applied to an increasingly diverse range of conditions
and the number of academic publications on the subject has
grown exponentially. In the UK the interest is so great that
an all-party group was formed to look at the potential
beneﬁts of mindfulness. Their recently produced report
(Mindful Nation UK)1 made recommendations for using
mindfulness in health, education, criminal justice and the
workplace.
What is mindfulness?
A popular working deﬁnition of mindfulness coined by Jon
Kabat-Zinn is learning to pay attention moment by
moment, intentionally, and with curiosity and compassion.2
Any object, internal or external, can be the focus of mindful
attention; however, in mindfulness training for psychiatric
disorders the chief emphasis is on deliberately attending to
internal experience, such as body sensations, thoughts and
emotions. There is a stress on noticing direct experience,
rather than getting caught up in the stories about the
experience. Importantly, the quality of attention is essentially
non-judgemental, emphasising interest and a sense of
kindness to whatever experience arises. Thus a core feature
of mindfulness is about how we pay attention to experience,
rather than the content of experience per se.
A brief history of mindfulness in the West
Mindfulness has been practised for over 2 millennia,
in particular in the Buddhist tradition. In the late 1970s
Kabat-Zinn set up a clinic in Massachusetts, USA, inviting
physicians to refer people with chronic pain or stress. He
delivered an 8-week course in mindfulness, and showed that
it beneﬁted people with chronic pain, also at a 4-year
follow-up.3,4 The course came to be called mindfulness-
based stress reduction (MBSR) and was found to be helpful
for a variety of conditions including anxiety,5 psoriasis,6
ﬁbromyalgia7 and enhancing immune function.8
Despite its popularity in North America, mindfulness
for health problems did not catch on greatly in the UK until
the work of Zindel Segal, Mark Williams and John
Teasdale.9 In 1992 they were tasked with developing
a maintenance form of cognitive therapy that could
prevent further episodes of depression in those currently
recovered, using a group format for cost-effectiveness.
Initially they intended to inject a little mindfulness into a
cognitive-behavioural therapy course, but ended up with
a mindfulness course with some elements added from
cognitive therapy. Their course, mindfulness-based
cognitive therapy (MBCT), drew heavily on Kabat-Zinn’s
MBSR. A three-centre randomised controlled trial showed
that MBCT halved the relapse rate in those with three or
more episodes of depression.
The publication of their work engendered a burgeoning
interest in the application of mindfulness as a therapeutic
approach, producing a whole family of mindfulness-based
interventions (MBIs). As well as being used as a stand-alone
treatment, mindfulness is also a component of other
treatment modalities such as dialectical behaviour therapy
(DBT) and acceptance and commitment therapy (ACT).
How does mindfulness work?
The simple version - useful for explaining mindfulness to
course participants - is the ABC of MBIs. ‘A’ stands for
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Summary Mindfulness is an increasingly popular therapeutic approach.
Mindfulness-based interventions have been tried out in a wide range of mental
disorders, with the strongest evidence for use in depression and anxiety. Mindfulness
operates by changing the person’s relationship with unhelpful thoughts and emotions.
The need for home practice is both a strength and a weakness. Some ﬁnd home
practice too demanding and a barrier to effective utilisation of mindfulness. Others
discover a set of practical tools that, once learnt, can be applied to ongoing life
difﬁculties; in this way mindfulness may have a place in promoting recovery beyond
the acute treatment of a disorder. Additionally, mindfulness may be beneﬁcial for
clinicians to promote well-being and enhance the therapeutic relationship.
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developing awareness. This is the foundation, with a
particular emphasis on cultivating body awareness. Usually
the ﬁrst main formal mindfulness practice that is
introduced is the body scan, in which one is led through
paying attention systematically to different parts of the
body. Usually within moments of starting the practice,
the mind gets caught up in thinking about something else.
The basic instruction is to notice when the mind wanders
off and then return to the body sensations. Noticing where
the mind has gone off to, one discovers in detail the habitual
patterns of the mind. Returning back to the body teaches
how to step out of being caught up in mental distractions.
‘B’ is for being with experience. Building on the
foundation of body awareness, once a person has gained
some familiarity with noting the mind going off and
returning back to the object of meditation (such as the
body sensations), the next step is to learn to turn towards
difﬁcult experience with an attitude of acceptance. This
counters typical reactions of pushing away unwanted
experience. Finally, ‘C’ is for making wise choices. Having
learnt to stay with persistent or painful experiences, one is
in a better position to judge what the most helpful thing to
do next is.
Being with difﬁcult thoughts or emotions is the crux of
MBIs, but it can feel counterintuitive. Usually, when
difﬁcult experiences arise they are avoided (e.g. by the use
of substances in addiction) or one is sucked into them in an
unhelpful way (such as with rumination in depression).
MBIs, through turning towards unwanted experience, steer
away from these twin responses of ‘blocking’ or ‘drowning’.
In many disorders there is an overuse of a conceptual
narrative focus; for example, in recurrent depression,
getting caught up in thoughts such as ‘Why do I feel so
bad?’, ‘What is wrong with me?’ or in social phobia, ‘What if
I can’t get my words out? People can see that I am red and
sweaty’.
A study using functional magnetic resonance imaging
(fMRI) suggests that mindfulness training leads to a move
away from narrative focus to experiential focus (attention
to direct sensory experience).10 Training produces a
decoupling of the medial prefrontal cortex (associated
with narrative focus) from the insula (viscero-somatic
signals), and an increased connection between the insula
and the lateral prefrontal cortex (associated with experiential
focus). That is, thoughts, feelings and body sensations are seen
less as good or bad, and more as transient mental events.
What is the evidence for MBIs?
The original work with MBCT has been extended to
suggest promising evidence for use in treatment-resistant
depression,11,12 in people with current symptoms of anxiety
or depression,13 including those currently depressed and
suicidal,14 and in improving residual symptoms regardless of
the number of previous episodes of depression.15 A recent
trial found similar relapse rates with those who used MBCT
to help taper off and discontinue antidepressant medication
(44% relapsed), and those remaining on antidepressant
medication without using MBCT (47% relapse rate).16 This
study indicated that those with a history of abuse did
particularly well with MBCT, suggesting that people most at
risk of relapse might beneﬁt most from MBCT. In bipolar
disorder MBCT does not appear to prevent relapse, but may
reduce anxiety and depressive symptoms between
episodes.17,18
Mindfulness may help to prevent relapse into addiction
by interrupting the automaticity of substance use in
response to triggers and by reducing unhelpful attention
biases and memory responses to triggers.19 A review of
seven randomised controlled trials showed that substance
use improved in ﬁve studies and was similar to controls in
two studies,20 with beneﬁts also found in subsequent
studies.21,22 There were improvements in some other
outcomes such as overall psychological and social adjust-
ment. Patient satisfaction was high and between half and
80% continued to practise mindfulness after the programme
had ﬁnished.
In the past meditation was thought to be contra-
indicated in people with psychosis. However, recent pilot
studies have shown that mindfulness may be safe. In this
population, it is recommended that practices are shorter,
guidance is more frequent, and explicit reference is made
to psychotic phenomena.23 Mindfulness may promote
acceptance of psychotic experiences and increase the
capacity to disengage from them.
Other areas with initial evidence for the usefulness of
mindfulness include eating disorders,24 obsessive-compulsive
disorder,25 hypochondriasis,26 somatisation disorders
(especially irritable bowel syndrome),27 autism-spectrum
disorders (in adults)28 and attention-deﬁcit hyperactivity
disorder.29
A meta-analysis by Khoury et al30 concluded that MBIs
are an effective treatment for a variety of psychological
problems, and especially for reducing anxiety, depression
and stress. They included 209 studies that consisted of
pre-post comparisons, waiting list controls and comparisons
with other active treatments. Not surprisingly, the strongest
evidence was for pre-post comparisons and against
waiting list controls. MBIs were more effective than
some psychological treatments, although there was no
difference in effectiveness when compared with traditional
cognitive–behavioural therapy, behaviour therapies or
pharmacological treatments.
An overview of reviews and meta-analyses by Gotink
et al31 suggested that, compared with waiting list controls
and other active treatments, MBIs improved depressive
symptoms, anxiety, stress, quality of life and physical
functioning.
What is the place of mindfulness now?
Mindfulness does not appear to be more effective than other
established treatments. However, where there is an evidence
base, it offers an alternative treatment approach, which may
either be a sufﬁcient treatment in its own right or may
complement other strategies. Thus, mindfulness may
increase the range of treatment choices for patients. Given
the potential usefulness of mindfulness in depression and
anxiety as well as in addiction, it has been suggested that
mindfulness may also be a helpful approach for patients
with dual diagnosis.32
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The plethora of popular books on mindfulness suggests
that it may have a wide appeal. One of the main factors that
can put patients off is the home practice, which some ﬁnd
too demanding. Typical courses in MBIs are characterised
by daily home practice for up to an hour, although there is a
trend towards shortening the practices. Home practice
appears to be linked to outcome, but the minimum effective
dose is not known. The corollary is that those who are able
to practise at home report coming away from a course with
a practical toolkit that they can continue to use after the
course has ﬁnished.
A possible advantage of mindfulness is as a life skill that
goes beyond the immediate treatment of a particular
disorder. Mindfulness training may therefore dovetail well
with the emphasis in treatment services on recovery. Some
patients may perceive mindfulness as a spiritual approach
to mental health problems, without needing to be afﬁliated
to any particular religious group.
Finally, practising mindfulness may be of beneﬁt for
clinicians themselves. The Mindful Nation UK report1
recommends developing mindfulness programmes for public
sector staff to combat stress and improve organisational
effectiveness. A number of studies have been conducted
among medical students and other health professionals. As
well as improving well-being,33 reducing mood disturbance
and helping to deal with stress,34 mindfulness training appears
to increase empathy levels.35 Thus, mindfulness may have
the potential to enhance the therapeutic relationship and so
beneﬁt clinical outcomes.
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The non-existence of mental illness
Arguing in The Myth of Mental Illness: Foundations of a
Theory of Personal Conduct that they are merely ‘indirect
forms of communication’,1 Thomas Szasz posited that
so-called mental illnesses cannot legitimately be categorised
as diseases. This launched an argument that Szasz would
elaborate over the course of a proliﬁc writing career that
spanned more than 50 years. Szasz repudiated psychiatry’s
misappropriation of concepts such as ‘illness’, which he took
to be relevant to medicine and its ‘physicalist framework’2
but not to matters of mind and human conduct. In The Myth
of Mental Illness,1 after arguing that virtually any entity can
have a counterfeit version, Szasz articulated his views with
characteristic iconoclasm, contending that only physical
illnesses are real and that mental diseases are ‘counterfeit
and metaphorical illnesses’ (p. 34). Illnesses are understood,
according to Szasz,3 with respect to deviation from a norm,
and in the case of physical illness the norm refers to the
structural or functional integrity of the body or some
aspect of it. But the norm - deviation from which results in
so-called mental illness - is altogether more problematic for
Szasz; this norm is a ‘psychosocial and ethical one’.3 With
this as the case, ﬁrst, the search for a medical remedy seems
poorly justiﬁed, and second, the points where diagnostic
lines are drawn are bound, according to Szasz, to be
somewhat arbitrary.
Szasz did not deny that humans have difﬁculties but he
preferred to conceptualise them not as mental illnesses or
as diseases, but as ‘problems in living’.1 Nor did he deny
psychiatrists a role in assisting individuals with problems.
Psychiatrists could have a legitimate role to play but the
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Summary Enfant terrible of psychiatry and widely known as one of its most
indefatigable as well as iconoclastic critics, Thomas Szasz (1961-2012) had a proliﬁc
writing career that extended some 51 years beyond the publication of his ﬁrst book,
The Myth of Mental Illness, in 1961. This editorial identiﬁes and critically discusses
three major themes in Szasz’s writings: his contention that there is no such thing as
mental illness, his contention that individual responsibility is never compromised in
those suffering from what is generally considered as mental illness, and his perennial
interest in calling attention to the political nature of psychiatric diagnosis.
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